Patents by Inventor Dibyendu De

Dibyendu De has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
    Patent number: 9782407
    Abstract: The present invention provides a method for treating or preventing a condition or disease in a human or an animal subject wherein the condition or disease is associated with lipoprotein metabolism, the method comprising administering to the subject a composition comprising benzylamine compounds.
    Type: Grant
    Filed: April 15, 2015
    Date of Patent: October 10, 2017
    Assignee: DR. REDDY'S LABORATORIES LTD.
    Inventors: Anima Baruah, Dibyendu De, Ish Kumar Khanna, Sivaram Pillarisetti, Santanu Maitra, Christopher W. Alexander, Jennepalli Sreenu, Indu Dager, Shanavas Alikunju
  • Benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors
    Patent number: 9765030
    Abstract: The present invention provides, among other things, new benzylamine compounds, compositions comprising benzylamine compounds, methods of making benzylamine compounds, and methods of using benzylamine compounds for treating or preventing a variety of conditions or diseases associated with lipoprotein metabolism.
    Type: Grant
    Filed: October 14, 2013
    Date of Patent: September 19, 2017
    Assignee: DR. REDDY'S LABORATORIES LTD.
    Inventors: Anima Baruah, Dibyendu De, Ish Kumar Khanna, Sivaram Pillarisetti, Santanu Maitra, Christopher W. Alexander, Jennepalli Sreenu, Indu Dager, Shanavas Alikunju
  • SUBSTITUTED BENZYLAMINO QUINOLINES AS CHOLESTEROL ESTER-TRANSFER PROTEIN INHIBITORS
    Publication number: 20150216866
    Abstract: The present invention provides a method for treating or preventing a condition or disease in a human or an animal subject wherein the condition or disease is associated with lipoprotein metabolism, the method comprising administering to the subject a composition comprising benzylamine compounds.
    Type: Application
    Filed: April 15, 2015
    Publication date: August 6, 2015
    Inventors: Anima BARUAH, Dibyendu DE, Ish Kumar KHANNA, Sivaram PILLARISETTI, Santanu MAITRA, Christopher W. ALEXANDER, Jennepalli SREENU, Indu DAGER, Shanavas ALIKUNJU
  • Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
    Patent number: 9040558
    Abstract: The invention is directed to novel substituted benzylamino quinolines, compounds comprising substituted benzylamino quinolines, methods of making substituted benzylamino quinolines, the use of substituted benzylamino quinolines for treating or preventing a variety of conditions or diseases associated with lipoprotein metabolism, and the use of substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors.
    Type: Grant
    Filed: December 28, 2005
    Date of Patent: May 26, 2015
    Assignee: DR. REDDY'S LABORATORIES LTD.
    Inventors: Anima Baruah, Dibyendu De, Ish Kumar Khanna, Sivaram Pillarisetti, Santanu Maitra, Christopher W. Alexander, Jennepalli Sreenu, Indu Dager, Shanavas Alikunju
  • NOVEL BENZYLAMINE DERIVATIVES AND THEIR UTILITY AS CHOLESTEROL ESTER-TRANSFER PROTEIN INHIBITORS
    Publication number: 20140134235
    Abstract: The present invention provides, among other things, new benzylamine compounds, compositions comprising benzylamine compounds, methods of making benzylamine compounds, and methods of using benzylamine compounds for treating or preventing a variety of conditions or diseases associated with lipoprotein metabolism.
    Type: Application
    Filed: October 14, 2013
    Publication date: May 15, 2014
    Applicant: DR. REDDY'S LABORATORIES LTD.
    Inventors: Anima BARUAH, Dibyendu DE, Ish Kumar KHANNA, Sivaram PILLARISETTI, Santanu MAITRA, Christopher W. ALEXANDER, Jennepalli SREENU, Indu Dagar, Shanavas Alikunju
  • HEMATOLOGY CONTROL COMPOSITIONS WITH EXTENDED STABILITY
    Publication number: 20140051063
    Abstract: The present specification provides hematology control compositions having particular utility with a red blood cell component for devices using electronic and optical means for blood determinations, and methods for using the compositions.
    Type: Application
    Filed: April 26, 2012
    Publication date: February 20, 2014
    Applicant: BECKMAN COULTER, INC.
    Inventors: Dibyendu De, Dennisse Parra-Diaz, Bruce Chin, Cristina Bagiotti-Sheldon
  • Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
    Patent number: 8604055
    Abstract: The present invention provides, among other things, new benzylamine compounds, compositions comprising benzylamine compounds, methods of making benzylamine compounds, and methods of using benzylamine compounds for treating or preventing a variety of conditions or diseases associated with lipoprotein metabolism.
    Type: Grant
    Filed: June 28, 2006
    Date of Patent: December 10, 2013
    Assignee: Dr. Reddy's Laboratories Ltd.
    Inventors: Anima Baruah, Dibyendu De, Ish Kumar Khanna, Sivaram Pillarisetti, Santanu Maitra, Christopher W. Alexander, Jennepalli Sreenu, Indu Dagar, Shanavas Alikunju
  • Biccyclic compounds as GATA modulators
    Patent number: 7989463
    Abstract: Novel bicyclic compounds of the formula (I), stereoisomers, and/or pharmaceutically acceptable salts of the novel bicyclic compounds, and/or pharmaceutically acceptable salts of the stereoisomers of the novel bicyclic compounds are provided. Additionally, methods of forming novel bicyclic compounds, stereoisomers, and/or pharmaceutically acceptable salts of the novel bicyclic compounds, and/or pharmaceutically acceptable salts of the stereoisomers of the novel bicyclic compounds are provided: wherein R1, R2, m, and n are defined herein.
    Type: Grant
    Filed: September 3, 2009
    Date of Patent: August 2, 2011
    Assignee: Dr. Reddy's Laboratories Limited
    Inventors: Dibyendu De, Ish Kumar Khanna, Sivaram Pillarisetti
  • Novel Biccyclic Compounds As GATA Modulators
    Publication number: 20100144731
    Abstract: Novel bicyclic compounds, stereoisomers, and/or pharmaceutically acceptable salts of the novel bicyclic compounds, and/or pharmaceutically acceptable salts of the stereoisomers of the novel bicyclic compounds are provided. Additionally, methods of forming novel bicyclic compounds, stereoisomers, and/or pharmaceutically acceptable salts of the novel bicyclic compounds, and/or pharmaceutically acceptable salts of the stereoisomers of the novel bicyclic compounds are provided.
    Type: Application
    Filed: September 3, 2009
    Publication date: June 10, 2010
    Applicant: Dr. Reddy's Laboratories Ltd.
    Inventors: Dibyendu De, Ish Kumar Khanna, Sivaram Pillarisetti
  • NOVEL HETEROCYCLIC COMPOUNDS AS GATA MODULATORS
    Publication number: 20100144722
    Abstract: Novel heterocyclic compounds, sstereoisomers thereof and/or pharmaceutically acceptable salts of formula (I) and its stereoisomers are provided. Additionally, methods of forming novel heterocyclic compounds, stereoisomers thereof and/or pharmaceutically acceptable salts of formula (I) and its stereoisomers are provided.
    Type: Application
    Filed: September 3, 2009
    Publication date: June 10, 2010
    Applicant: Dr. Reddy's Laboratories Ltd.
    Inventors: Christopher W. Alexander, Dibyendu De, Ish Kumar Khanna, Sivaram Pillarisetti
  • Novel benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors
    Publication number: 20070015758
    Abstract: The present invention provides, among other things, new benzylamine compounds, compositions comprising benzylamine compounds, methods of making benzylamine compounds, and methods of using benzylamine compounds for treating or preventing a variety of conditions or diseases associated with lipoprotein metabolism.
    Type: Application
    Filed: June 28, 2006
    Publication date: January 18, 2007
    Inventors: Anima Baruah, Dibyendu De, Ish Khanna, Sivaram Pillarisetti, Santanu Maitra, Christopher Alexander, Jennepalli Sreenu, Indu Dager
  • Melt-spun polysulfone semipermeable membranes and methods for making the same
    Patent number: 7144505
    Abstract: The present invention provides, inter alia, a composition useful for producing a homogeneous, semipermeable membrane, the composition comprising a polysulfone semipermeable membrane, the polysulfone semipermeable membrane comprising a mixture of: an ultra-high-molecular-weight hydrophilic polymer, a polysulfone compound and a solvent for the polysulfone compound, and the polysulfone semipermeable membrane having a homogeneous structure such that the polysulfone semipermeable membrane has a substantially uniform structure. Another aspect of this invention discloses methods for fabricating semipermeable membranes by homogeneously mixing the composition, melting the composition, and melt-spinning the molten composition. Another aspect of the present invention includes homogeneous, melt-spun, semipermeable membranes useful for liquid separation processes, such as, but not limited to, microfiltration, ultrafiltration, dialysis, and reverse osmosis.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: December 5, 2006
    Assignees: Baxter International Inc., Baxter Healthare S.A.
    Inventors: Wenli Han, Martin Ketterer, Jonnie Lee, Thanh Nguyen, George Washington, Delores Jordan, Dibyendu De
  • Novel benzylamine derivatives as CETP inhibitors
    Publication number: 20060178514
    Abstract: The present invention provides, among other things, new benzylamine compounds, compositions comprising benzylamine compounds, methods of making benzylamine compounds, and methods of using benzylamine compounds for treating or preventing a variety of conditions or diseases associated with lipoprotein metabolism.
    Type: Application
    Filed: December 28, 2005
    Publication date: August 10, 2006
    Inventors: Anima Baruah, Dibyendu De, Ish Khanna, Sivaram Pillarisetti, Santanu Maitra, Christopher Alexander, Jennepalli Sreenu
  • Use of estrogen related receptor-modulating aryl ethers
    Publication number: 20060014812
    Abstract: Therapeutic methods of using certain heterocyclic arylidene aryl ether compounds for treating diseases or disorders mediated through modulation of estrogen related receptor alpha are described.
    Type: Application
    Filed: July 8, 2005
    Publication date: January 19, 2006
    Inventors: Mark Player, Richard Pottorf, Dionisios Rentzeperis, Dibyendu De
  • Melt-spun polysulfone semipermeable membranes and methods for making the same
    Publication number: 20040026315
    Abstract: The present invention provides, inter alia, a composition useful for producing a homogeneous, semipermeable membrane, the composition comprising a polysulfone semipermeable membrane, the polysulfone semipermeable membrane comprising a mixture of: an ultra-high-molecular-weight hydrophilic polymer, a polysulfone compound and a solvent for the polysulfone compound, and the polysulfone semipermeable membrane having a homogeneous structure such that the polysulfone semipermeable membrane has a substantially uniform structure. Another aspect of this invention discloses methods for fabricating semipermeable membranes by homogeneously mixing the composition, melting the composition, and melt-spinning the molten composition. Another aspect of the present invention includes homogeneous, melt-spun, semipermeable membranes useful for liquid separation processes, such as, but not limited to, microfiltration, ultrafiltration, dialysis, and reverse osmosis.
    Type: Application
    Filed: December 20, 2002
    Publication date: February 12, 2004
    Inventors: Wenli Han, Martin Ketterer, Jonnie Lee, Thanh Nguyen, George Washington, Delores Jordan, Dibyendu De